Effect of duration of postherpetic neuralgia on efficacy analyses in a multicenter, randomized, controlled study of NGX-4010, an 8% capsaicin patch evaluated for the treatment of postherpetic neuralgia
Lynn R. Webster(Adherent Technologies (United States)), Geertrui F. Vanhove, Marvin Tark, Jeffrey Tobias(Jazz Pharmaceuticals (United States)), Richard Rauck(Carolinas Pain Institute)
Cited by 55
Related Papers
Predicting Aberrant Behaviors in Opioid-Treated Patients: Preliminary Validation of the Opioid Risk Tool
|Pain Medicine|2005|1.1k
Efficacy and Safety of Tifacogin (Recombinant Tissue Factor Pathway Inhibitor) in Severe Sepsis
|JAMA|2003|958
Risk Factors for Opioid-Use Disorder and Overdose
|Anesthesia & Analgesia|2017|504
Consensus practice guidelines on interventions for lumbar facet joint pain from a multispecialty, international working group
|Regional Anesthesia & Pain Medicine|2020|370
Naloxegol for Opioid-Induced Constipation in Patients with Noncancer Pain
|New England Journal of Medicine|2014|331